Baseball’s Drug War
Major and minor league baseball players missed more than 25,000 games from 2007 through 2014 while suspended for using performance-enhancing drugs. That was after the era of Barry Bonds, Sammy Sosa and Mark McGwire. The figure is bigger than the number of games played by all 30 U.S. Major League Baseball teams over five seasons. It stands as evidence of the persistence of drug use in baseball, as in other sports, in the face of efforts to clean it up.
Before the 2015 season was a week old, four Major League pitchers had been suspended for using steroids. The suspensions came a year after Major League Baseball and its players’ union strengthened the strictest drug policy among the four big U.S. sports leagues. A failed first test now brings an 80-game ban, and a second positive result will cost the violator a full season, 162 games. Baseball also expanded testing for human growth hormone, a popular but unproven muscle-building drug with potentially harmful side effects. (The National Football League started HGH testing in September.) The most prominent player suspended was Alex Rodriguez, a three-time Most Valuable Player who was one of 14 players linked to illicit treatments at a defunct Florida anti-aging clinic called Biogenesis. He was banned for the entire 2014 season then returned to the New York Yankees in 2015. Twelve others suspended with Rodriguez in 2013 served their 50-game bans in 2014. Ryan Braun of the Milwaukee Brewers, the 2011 National League MVP, accepted a 65-game sanction. None of them were caught through testing, as advanced performance-enhancing drugs are difficult to detect. The Biogenesis scandal came 5½ years after former Senator George Mitchell’s searing 2007 report linking 89 players to steroid use — an assessment Commissioner Bud Selig termed “a call to action,” pledging, “I will act.”
Baseball was losing ground to other professional sports even before a players’ strike wiped out the 1994 World Series and undermined the game’s claim to be America’s national pastime. Drug use pumped up a subsequent rebound in popularity that owed much to an explosion of slugging records, including a 1998 home run battle that saw McGwire and Sosa break Roger Maris’s 37-year-old single-season home run landmark. The Mitchell Report named as drug users seven MVPs, two Cy Young Award-winning pitchers, and 31 All-Stars including McGwire and Sosa, and said Major League Baseball and the players’ union knew about illicit drug use and tolerated it. Since then the sport has handed down more than 400 doping suspensions throughout the major and minor leagues. With MLB’s average salary at over $4 million, the side effects of drug use, the penalties and the shame of being caught haven’t been enough to deter cheaters.
Are the tainted superstars of the steroid era an insult whose memory should be expunged from a history-rich game? Or are they legitimate athletes guilty of nothing worse than stretching for success in a medicalized era? The debate is under way. International cycling and track are plagued by drug use and the NFL and NBA are working to head it off. But no sport cherishes its statistical heritage like Major League Baseball, now 139 years old. Hall of Fame voters didn’t elect anyone in 2013, and snubbed those tied to doping the next two years. Seven-time Cy Young Award winner Roger Clemens received 37.5 percent of the vote in 2015, half of what was needed for election. Home-run king Bonds drew 36.8 percent and McGwire 10 percent. With Rodriguez rising to equal achievement and notoriety, his place among the game’s greats is also certain to be contested.
The Reference Shelf
- The Mitchell Report
- List of drugs prohibited by the World Anti-Doping Agency, which oversees Olympic sports. None of the major U.S. sports leagues have adopted the WADA code entirely.
- Text of Major League Baseball’s Drug Prevention and Treatment Program.
- Chart from the U.S. Anti-Doping Agency detailing side effects of performance-enhancing drugs.
- Miami New Times reports on the Biogenesis clinic scandal.
First published Oct. 23, 2013
To contact the editor responsible for this QuickTake:
Jonathan Landman at firstname.lastname@example.org